RECURRENT HAIRY CELL LEUKEMIA VARIANT

Clinical trials for RECURRENT HAIRY CELL LEUKEMIA VARIANT explained in plain language.

Never miss a new study

Get alerted when new RECURRENT HAIRY CELL LEUKEMIA VARIANT trials appear

Sign up with your email to follow new studies for RECURRENT HAIRY CELL LEUKEMIA VARIANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New pill trial targets Tough-to-Treat blood cancer comeback

Disease control Recruiting now

This study is testing whether a pill called venetoclax can help control hairy cell leukemia that has come back after previous treatments. About 20 adults whose cancer has relapsed will take the daily pill for up to 19 months. Researchers want to see if the treatment shrinks the c…

Matched conditions: RECURRENT HAIRY CELL LEUKEMIA VARIANT

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

RECURRENT HAIRY CELL LEUKEMIA VARIANT

Get alerted when new RECURRENT HAIRY CELL LEUKEMIA VARIANT trials appear

New pill trial targets Tough-to-Treat blood cancer comeback